Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2009 - 2026)
Zimmer Biomet Holdings' quarterly Shares Outstanding (Weighted Average) came in at $195.0 million in Q1 2026, down 1.96% year-on-year from $198.9 million in Q1 2025, and down 1.52% quarter-over-quarter from $198.0 million in Q4 2025.
Zimmer Biomet Holdings has reported Shares Outstanding (Weighted Average) for 11 years, with the latest figure at $195.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.96% year-over-year to $195.0 million; the trailing twelve-month figure through Mar 2026 stood at $195.0 million (down 1.96% YoY), and the FY2025 full-year result was $198.0 million, down 2.51% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $195.0 million, down from $198.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $209.8 million in Q3 2022, with the low at $195.0 million in Q1 2026.
- Average Shares Outstanding (Weighted Average) over 5 years is $204.0 million, with a median of $205.2 million recorded in 2024.
- Year-over-year, Shares Outstanding (Weighted Average) slipped 0.38% in 2023 and retreated 3.41% in 2025.
- Tracing ZBH's Shares Outstanding (Weighted Average) over 5 years: stood at $209.6 million in 2022, then fell by 0.43% to $208.7 million in 2023, then retreated by 2.68% to $203.1 million in 2024, then fell by 2.51% to $198.0 million in 2025, then fell by 1.52% to $195.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $195.0 million (Q1 2026), $198.0 million (Q4 2025), and $198.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 195.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.00 Mn |
| Dec 31, 2025 | 198.00 Mn |
| Sep 30, 2025 | 198.30 Mn |
| Jun 30, 2025 | 198.40 Mn |
| Mar 31, 2025 | 198.90 Mn |
| Dec 31, 2024 | 203.10 Mn |
| Sep 30, 2024 | 202.30 Mn |
| Jun 30, 2024 | 205.40 Mn |
| Mar 31, 2024 | 205.20 Mn |
| Dec 31, 2023 | 208.70 Mn |
| Sep 30, 2023 | 209.00 Mn |
| Jun 30, 2023 | 208.60 Mn |
| Mar 31, 2023 | 209.40 Mn |
| Dec 31, 2022 | 209.60 Mn |
| Sep 30, 2022 | 209.80 Mn |
| Sep 30, 2014 | 169.00 Mn |
| Jun 30, 2014 | 168.40 Mn |
| Mar 31, 2014 | 169.10 Mn |
| Dec 31, 2013 | 169.60 Mn |
| Sep 30, 2013 | 170.00 Mn |
| Jun 30, 2013 | 168.80 Mn |
| Mar 31, 2013 | 168.70 Mn |
| Dec 31, 2012 | 174.90 Mn |
| Sep 30, 2012 | 175.60 Mn |
| Jun 30, 2012 | 175.20 Mn |
| Mar 31, 2012 | 177.40 Mn |
| Dec 31, 2011 | 187.60 Mn |
| Sep 30, 2011 | 187.70 Mn |
| Jun 30, 2011 | 191.50 Mn |
| Mar 31, 2011 | 192.60 Mn |
| Dec 31, 2010 | 200.00 Mn |
| Sep 30, 2010 | 198.70 Mn |
| Jun 30, 2010 | 202.40 Mn |
| Mar 31, 2010 | 203.00 Mn |
| Dec 31, 2009 | 215.00 Mn |
| Sep 30, 2009 | 216.60 Mn |
| Jun 30, 2009 | 218.10 Mn |
| Mar 31, 2009 | 221.50 Mn |